Đang chuẩn bị liên kết để tải về tài liệu:
Determination of lesinurad in rat plasma by a UHPLC–MS/MS assay

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Lesinurad is an oral inhibitor of urate-anion exchanger transporter 1 and has been approved by the US Food and Drug Administration for combination therapy with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with refractory gout. | Determination of lesinurad in rat plasma by a UHPLC MS MS assay

TÀI LIỆU LIÊN QUAN

Minimum inhibitory concentration (MIC) determination of herbal extracts against Escherichia coli, Salmonella Typhimurium, and Staphylococcus aureus

Comparative evaluation of visual and colorimetric methods of teeth color determination

Distinct sperm nucleus behaviors between genotypic and temperature-dependent sex determination males are associated with replication and expression-related pathways in a gynogenetic fish

ADVANCES IN SPACECRAFT SYSTEMS AND ORBIT DETERMINATION

Development of spectrophotometric method for determination of mesalazine in pharmaceutical preparation

Robust attitude determination using multiple antennas GNSS carrier phase measurement for UAV applications

A dynamic model for GPS based attitude determination and testing using a serial robotic manipulator

Unequivocal glycyrrhizin isomer determination and comparative in vitro bioactivities of root extracts in four Glycyrrhiza species

Method development for the simultaneous determination of paracetamol and diclofenac in pharmaceutical formulations by capillary zone electrophoresis

Chemical constituents of Albizia myriophylla wood and the HPLC determination of some high yield compounds as markers
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.